Fundz

Tubulis raised $138M in an upsized Series B2 financing led by EQT Life Sciences and Nextech Invest to advance clinical trials for lead ADC candidates and expand presence in the U.S.

PRIVATEMar 14, 2024

Amount Raised

$139 Million

Round Type

Series B

MunichBiotechnologyHealth Care

Investors

High Tech GründerfondsOccidentSeventure PartnersCoparionEvotecBayern KapitalFund+Bio Med PartnersAndera PartnersDeep Track CapitalFrazier Life SciencesNextech InvestEQT Life Sciences

Description

Tubulis, a German biotech company, secured 128 million euros ($138.8 million) in an upsized series B2 financing round. The funding will be used to advance clinical trials for their lead ADC candidates, TUB-040 and TUB-030, while also expanding their presence in the U.S. and enhancing technology platforms for ADC development.

Quick answer

Tubulis raised $139 Million in a Series B round, dated March 14, 2024. Investors: High Tech Gründerfonds, Occident, Seventure Partners, Coparion, Evotec, Bayern Kapital, Fund+ and Bio Med Partners. Tubulis is based in Munich, Bavaria, Germany.

How much did Tubulis raise?
Tubulis raised $139 Million in a Series B round on March 14, 2024.
Who invested in Tubulis?
High Tech Gründerfonds, Occident, Seventure Partners, Coparion, Evotec, Bayern Kapital, Fund+ and Bio Med Partners are named as investors in this round.
What does Tubulis do?
Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.
Where is Tubulis based and how big is it?
Tubulis is based in Munich, Bavaria, Germany. Fundz records about 73 employees.
Who are the decision-makers at Tubulis?
Fundz holds 1 contact at Tubulis. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Tubulis that raised within 45 days of this round, from Fundz verified event records.

  • FOXO Technologies raised $110K on April 28, 2024.
  • Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
  • Variantyx raised $36M (Funding Round) on April 26, 2024.
  • Owlstone Medical raised $6.5M (Grant) on April 25, 2024.
  • neurocare raised $17M (Funding Round) on April 24, 2024.
  • Sydnexis raised $1000K (Series B) on April 24, 2024.

Who to call at Tubulis, and when

A new round usually means Tubulis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Tubulis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tubulis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tubulis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tubulis

Location

Munich, Bavaria, Germany

About

Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. We will advance a range of conjugates, unlimited by indication, using our own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tubulis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Tubulis's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Tubulis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.